Abstract

Cortical interneurons establish inhibitory microcircuits throughout the neocortex and their dysfunction has been implicated in epilepsy and neuropsychiatric diseases. Developmentally, interneurons migrate from a distal progenitor domain in order to populate the neocortex - a process that occurs at a slower rate in humans than in mice. In this study, we sought to identify factors that regulate the rate of interneuron maturation across the two species. Using embryonic mouse development as a model system, we found that the process of initiating interneuron migration is regulated by blood vessels of the medial ganglionic eminence (MGE), an interneuron progenitor domain. We identified two endothelial cell-derived paracrine factors, SPARC and SerpinE1, that enhance interneuron migration in mouse MGE explants and organotypic cultures. Moreover, pre-treatment of human stem cell-derived interneurons (hSC-interneurons) with SPARC and SerpinE1 prior to transplantation into neonatal mouse cortex enhanced their migration and morphological elaboration in the host cortex. Further, SPARC and SerpinE1-treated hSC-interneurons also exhibited more mature electrophysiological characteristics compared to controls. Overall, our studies suggest a critical role for CNS vasculature in regulating interneuron developmental maturation in both mice and humans.

Data availability

Bulk RNA-seq datasets for HEK293 and HBEC 5i have been uploaded to NCBI GEO under Accession Number: GSE146991

The following data sets were generated

Article and author information

Author details

  1. Matthieu Genestine

    Pathology and cell biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Daisy Ambriz

    Pathology and cell biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Gregg W Crabtree

    Pathology and cell biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Patrick Dummer

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Anna Molotkova

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Michael Quintero

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Angeliki Mela

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Saptarshi Biswas

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Huijuan Feng

    Systems Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Chaolin Zhang

    Department of Systems Biology, Department of Biochemistry and Molecular Biophysics, Center for Motor Neuron Biology and Disease, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8310-7537
  11. Peter Canoll

    Department of Systems Biology, Department of Biochemistry and Molecular Biophysics, Center for Motor Neuron Biology and Disease, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Gunnar Hargus

    Department of Systems Biology, Department of Biochemistry and Molecular Biophysics, Center for Motor Neuron Biology and Disease, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Dritan Agalliu

    Neurology, Pathology and Cell Biology, Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Joseph A Gogos

    Neurology, Pathology and Cell Biology, Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Edmund Au

    Pathology and Cell Biology, Columbia University, New York, United States
    For correspondence
    ea2515@cumc.columbia.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3190-9711

Funding

Whitehall Foundation (2016-12-137)

  • Edmund Au

Irma T. Hirschl Trust

  • Edmund Au

National Institutes of Health (R03MH119443-01)

  • Edmund Au

National Institutes of Health (R01NS117695)

  • Edmund Au

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocol (AC-AAAZ6451) of Columbia University .

Human subjects: We obtained fetal tissue samples for research following induced termination of pregnancy for maternal indications. Sample collection followed the policies of the Columbia University Irving Medical Center Institutional Review Board. IRB waiver AAAS5541 was obtained for non-human subjects research, deemed medical waste.

Copyright

© 2021, Genestine et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,464
    views
  • 235
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Matthieu Genestine
  2. Daisy Ambriz
  3. Gregg W Crabtree
  4. Patrick Dummer
  5. Anna Molotkova
  6. Michael Quintero
  7. Angeliki Mela
  8. Saptarshi Biswas
  9. Huijuan Feng
  10. Chaolin Zhang
  11. Peter Canoll
  12. Gunnar Hargus
  13. Dritan Agalliu
  14. Joseph A Gogos
  15. Edmund Au
(2021)
Vascular-derived SPARC and SerpinE1 regulate interneuron tangential migration and maturation
eLife 10:e56063.
https://doi.org/10.7554/eLife.56063

Share this article

https://doi.org/10.7554/eLife.56063

Further reading

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Olivia B Taylor, Nicholas DeGroff ... Andy J Fischer
    Research Article

    The purpose of these studies is to investigate how Sphingosine-1-phosphate (S1P) signaling regulates glial phenotype, dedifferentiation of Müller glia (MG), reprogramming into proliferating MG-derived progenitor cells (MGPCs), and neuronal differentiation of the progeny of MGPCs in the chick retina. We found that S1P-related genes are highly expressed by retinal neurons and glia, and levels of expression were dynamically regulated following retinal damage. Drug treatments that activate S1P receptor 1 (S1PR1) or increase levels of S1P suppressed the formation of MGPCs. Conversely, treatments that inhibit S1PR1 or decrease levels of S1P stimulated the formation of MGPCs. Inhibition of S1P receptors or S1P synthesis significantly enhanced the neuronal differentiation of the progeny of MGPCs. We report that S1P-related gene expression in MG is modulated by microglia and inhibition of S1P receptors or S1P synthesis partially rescues the loss of MGPC formation in damaged retinas missing microglia. Finally, we show that TGFβ/Smad3 signaling in the resting retina maintains S1PR1 expression in MG. We conclude that the S1P signaling is dynamically regulated in MG and MGPCs in the chick retina, and activation of S1P signaling depends, in part, on signals produced by reactive microglia.

    1. Developmental Biology
    Kayleigh Bozon, Hartmut Cuny ... Sally L Dunwoodie
    Research Article

    Congenital malformations can originate from numerous genetic or non-genetic factors but in most cases the causes are unknown. Genetic disruption of nicotinamide adenine dinucleotide (NAD) de novo synthesis causes multiple malformations, collectively termed Congenital NAD Deficiency Disorder (CNDD), highlighting the necessity of this pathway during embryogenesis. Previous work in mice shows that NAD deficiency perturbs embryonic development specifically when organs are forming. While the pathway is predominantly active in the liver postnatally, the site of activity prior to and during organogenesis is unknown. Here, we used a mouse model of human CNDD and assessed pathway functionality in embryonic livers and extraembryonic tissues via gene expression, enzyme activity and metabolic analyses. We found that the extra-embryonic visceral yolk sac endoderm exclusively synthesises NAD de novo during early organogenesis before the embryonic liver takes over this function. Under CNDD-inducing conditions, visceral yolk sacs had reduced NAD levels and altered NAD-related metabolic profiles, affecting embryo metabolism. Expression of requisite pathway genes is conserved in the equivalent yolk sac cell type in humans. Our findings show that visceral yolk sac-mediated NAD de novo synthesis activity is essential for mouse embryogenesis and its perturbation causes CNDD. As mouse and human yolk sacs are functionally homologous, our data improve the understanding of human congenital malformation causation.